0
Erratum |

Correction to Results, Table, and Figure in: Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD. FREE TO VIEW

Author and Funding Information

Copyright 2017, . All Rights Reserved.


Chest. 2017;151(6):1410. doi:10.1016/j.chest.2017.05.001
Text Size: A A A
Published online

The authors have reported to CHEST that an error appeared in the text, Figure 3, and Tables 3 and 4 in “Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD” (Chest. 2017;151(2):340-357).

In line 4 of the Results/Efficacy section, the P value should read P < .0001 in PINNACLE-1 and P < .02 in PINNACLE-2. In addition, the legends for Figures 3 and 4 should read mean change (± SE). A corrected version of Figure 3 is available online.

In Table 3, the third LSM entry in column 1 reading across to PINNACLE-2 (GP MDI), value should read −.036d.

In Table 4, the number of patients with TEAEs related to study treatment in the Placebo MDI group in PINNACLE-2 should be 15 (6.7).

These corrections do not change the conclusions. The online article has been corrected.


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543